Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Revival Gold Reports Positive Metallurgical Tests Results at Mercur
-
First Trust Introduces a Small and Mid Cap Dividend Achievers ETF
-
Cytokinetics Announces Data From Phase 1 Study of CK-4021586
-
Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
-
Recognize Announces Majority Investment in Managed Services Leader Blue Mantis
-
ALLIED GOLD TO COMMENCE TRADING ON OTCQX EXCHANGE
-
Somite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite's Cell Therapy Flagship Program
-
First Citizens Bank Serves as Co-Lead Arranger on $300 Million Credit Facility for Swift Current Energy
-
Titan Announces Q&A Session with Shareholders
-
Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
-
Papa Johns Announces Kevin Vasconi as Chief Digital and Technology Officer
-
SelectQuote to Release Fiscal Fourth Quarter and Full Year 2024 Earnings on September 13
-
Watsco to Present at the 12th Annual Morgan Stanley Laguna Conference on September 11, 2024 at 3:10 p.m. PDT
-
Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024
-
Vecima Returns to IBC 2024 to Highlight Video Industry Innovation
-
Mobileye to End Internal Lidar Development
-
PlusInvesting Launches New Feature to Enhance Trading Efficiency for Canadian Users
-
Progress to Acquire ShareFile
-
NIP Group Inc. Enters Game Publishing Market, Expanding Digital Entertainment Ecosystem
-
FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
-
Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaen
-
Prelude Therapeutics Announces Publication of Abstract for Presentation at the European Society of Medical Oncology (ESMO) Congress 2024
-
Titan Announces Q&A Session with Shareholders
-
Theratechnologies to Present at Upcoming Investor Conferences in September
-
Data Center Developer and Operator Dataprana to Launch its First 30MW Immersion Site
-
PlusInvesting Launches New Feature to Enhance Trading Efficiency for Canadian Users
-
Collective Voice Report: Brands and Creators Should Rethink Their Content Strategy in the Election Season
-
Fury Intercepts 12.16 g/t Gold Over 3 Metres at Serendipity
-
Natural Grocers® Announces Collaboration with Bitchin' Sauce to Benefit the Natural Grocers Heroes in Aprons Fund
-
Inaugural Hong Kong Shopping Festival ends successfully
-
CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
-
Windfall of Historic Geophysical Data Advances Exploration and Targeting at the Filo Sur Project in the Vicuña District Argentina.
-
-
Half-year report 2024
-
Global MMA Superstar Conor McGregor Increases His Ownership Stake in Alta Global Group with Performance Shares Vesting at up to $20 per Share
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
New Data: Battery Thermal Runaway Incidents on Board Passenger and Cargo Aircraft Hit Record High as Passengers Remain Largely Unaware of Risks
-
Gryphon Digital Mining to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9, 2024 at 11:00am ET
-
Mooresville Ford Receives JD Power Dealer of Excellence Award
-
Vyne Dental Named Quarterfinalist in 2024 Digital Health Hub Foundation Awards
-
Domino's® is Saying No to Shrinkflation by Launching MOREflation
-
GENERATIONAL DIVIDE EMERGING ON INTERNATIONAL EDUCATION, HSBC DATA FINDS
-
Jiangsu-Germany Dialogue 2024 Held in Changzhou
-
Behind Enemy Lines: The True Story of a CIA Operative’s Fight Against Trafficking
-
MMI launches Refinder mortgage refinance tool to help lenders prepare for expected interest rate decline
-
Sport facility in The Hague heated by the local sewer
-
Kraig Biocraft Laboratories Completes New Production Center, Expands Capacity more than Eightfold
-
Circle Pharma Announces Preclinical Data Poster Presentation of CID-078, a First-and-Only-in-Class Cyclin A/B RxL Inhibitor at the 2024 World Conference on Lung Cancer
-
Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
-
OraSure Technologies Elects Jack Kenny to the Board of Directors
